Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer

Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer

Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer

Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens

Plasminogen activator profiles in neoplastic tissues of the human colon

Plasminogeenaktivatoren in (pre)maligne aandoeningen van het colon

Plasminogeenactivatoren in adenocarcinomen van het colon